|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | GlaxoSmithKline |
|---|---|
| Information provided by: | GlaxoSmithKline |
| ClinicalTrials.gov Identifier: | NCT00460226 |
Purpose
This is multi-center, prospective, observational stud. This study is designed to evaluate the rate of non-serious rash in Korean bipolar I patients.
| Condition | Intervention |
|---|---|
|
Bipolar Disorder |
Drug: lamotrigine |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | A Multi-centre, Observational Study to Evaluate the Incidence of Non-serious Rash in Korean Bipolar I Patients With Lamotrigine Therapy in Real World Setting |
| Enrollment: | 238 |
| Study Start Date: | March 2007 |
| Study Completion Date: | December 2007 |
| Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
lamotrigine
there is only one group.
|
Drug: lamotrigine
lamotrigine treatment for 12weeks
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patient setting and reflecting usual clinical practice in general hospital
Inclusion criteria:
Exclusion criteria:
Contacts and Locations
More Information
| Responsible Party: | GSK ( Study Director ) |
| Study ID Numbers: | LBI108245 |
| Study First Received: | April 12, 2007 |
| Last Updated: | August 13, 2009 |
| ClinicalTrials.gov Identifier: | NCT00460226 History of Changes |
| Health Authority: | Korea: Food and Drug Administration |
|
Lamotrigine Non-serious rash Bipolar I disorder Korean |
|
Disease Molecular Mechanisms of Pharmacological Action Bipolar Disorder Calcium Channel Blockers Cardiovascular Agents Pharmacologic Actions Membrane Transport Modulators Affective Disorders, Psychotic |
Pathologic Processes Mental Disorders Therapeutic Uses Mood Disorders Lamotrigine Central Nervous System Agents Anticonvulsants |